Orphan Designation
FDA Approves Orphan Drug to Treat Aplastic Anemia
On February 21, 2013, the U.S. Food and Drug Administration (“FDA”) granted orphan drug status to an aplastic anemia treatment.…
FDA Approves New Orphan Drug (Elelyso) to Treat Gaucher Disease
On May 1, 2012, the U.S. Food and Drug Administration (“FDA”) approved a new orphan drug to treat Gaucher disease.…